Literature DB >> 19616149

An overview of the cancer burden for primary care physicians.

Michael Thun1, Ahmedin Jemal, Carol Desantis, Bonny Blackard, Elizabeth Ward.   

Abstract

Primary care physicians and other caregivers are uniquely positioned to communicate with patients about their real risks of developing or dying from cancer and actions that can reduce these risks. This article discusses the statistics used to measure the cancer burden in a manner intended to help primary caregivers communicate more effectively with patients about cancer. The basic terms used to measure incidence, mortality, and relative survival, and considerations that influence the interpretation of cancer trends are described; opportunities to accelerate progress in reducing cancer incidence and death rates are identified. Although integrating effective prevention measures into standard clinical care will require changes in health care policy and in clinical practice, the combination of these approaches is essential to prevent the massive anticipated increase in the number of cancer cases, due to growth and aging of the population.

Entities:  

Mesh:

Year:  2009        PMID: 19616149     DOI: 10.1016/j.pop.2009.04.001

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  5 in total

1.  Ataxin-3 expression correlates with the clinicopathologic features of gastric cancer.

Authors:  Li-Xia Zeng; Yong Tang; Yun Ma
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.

Authors:  Deng Luo; Hua Huang; Ming-Liang Lu; Gong-Fang Zhao; Jiang Chang; Meng-Yao Zheng; Yan Wang
Journal:  Pathol Oncol Res       Date:  2011-11-23       Impact factor: 3.201

3.  Lifetime risk for cancer death by sex and smoking status: the lifetime risk pooling project.

Authors:  Andrew Gawron; Lifang Hou; Hongyan Ning; Jarett D Berry; Donald M Lloyd-Jones
Journal:  Cancer Causes Control       Date:  2012-07-24       Impact factor: 2.506

4.  Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer.

Authors:  Deng Luo; Ming-Liang Lu; Gong-Fang Zhao; Hua Huang; Meng-Yao Zheng; Jiang Chang; Lin Lv; Jin-Bo Luo
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

5.  Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients.

Authors:  Deng Luo; Ting Ye; Tian-Qian Li; Peng Tang; Sha-Dong Min; Gong-Fang Zhao; Hua Huang; Jiang Chang; Yan Wang; Lin Lv; Ming-Liang Lu; Meng-Yao Zheng
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.